Recommendations
|
DA Davidson analyst Linda… ShowHide Related Items >><< - 11/03/22
- 1-800-Flowers.com sees generating over $75M in free cash flow in FY23
- 09/02/22 DA Davidson
- 1-800-Flowers.com price target lowered to $7.00 from $9.25 at DA Davidson
- 09/02/22 Benchmark
- 1-800-Flowers.com price target lowered to $13 from $17 at Benchmark
- 04/29/22 Benchmark
- 1-800-Flowers.com price target lowered to $17 from $26 at Benchmark
- 04/28/22 Craig-Hallum
- Craig-Hallum downgrades 1-800-Flowers, says things could get worse before better
- 02/02/23
- 1-800-Flowers.com sees FY23 revenue decline in the mid-single digit range
- 02/02/23
- 1-800-Flowers.com reports Q2 EPS $1.27, consensus 95c
- 11/03/22
- 1-800-Flowers.com sees FY23 revenue down in mid single digits, consensus $2.17B
- 11/03/22
- 1-800-Flowers.com reports Q1 EPS (52c), consensus (54c)
|
Downgrade
|
SMBC Nikko analyst Andrew… ShowHide Related Items >><< - 02/02/23
- Bill.com announces $300M share repurchase program
- 11/03/22
- Bill.com to acquire Finmark, terms not disclosed
- 09/12/22
- Bill.com announces Loren Padelford joins company as CCO
- 08/19/22
- Bill.com rises 14.5%
- 08:28 Today BTIG
- Bill.com cut to Neutral at BTIG on disappointing outlook
- 08:24 Today BTIG
- Bill.com downgraded to Neutral from Buy at BTIG
- 08:18 Today Morgan Stanley
- Bill.com price target lowered to $185 from $200 at Morgan Stanley
- 07:58 Today Susquehanna
- Bill.com price target lowered to $140 from $190 at Susquehanna
- 02/02/23
- Bill.com raises FY23 EPS view to 99c-$1.05 from 48c-59c, consensus 55c
- 02/02/23
- Bill.com sees Q3 adjusted EPS 22c-25c, consensus 12c
- 02/02/23
- Bill.com reports Q2 adjusted EPS 42c, consensus 13c
- 02/02/23
- Notable companies reporting after market close
- 02/02/23
- Fly Intel: After-Hours Movers
- 01/27/23
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 01/13/23
- Sell these stocks now, proven algorithm says
- 01/11/23
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 02/02/23
- Bill.com Holdings options imply 13.1% move in share price post-earnings
- 01/23/23
- Bill.com Holdings call volume above normal and directionally bullish
- 12/28/22
- Bill.com Holdings put volume heavy and directionally bearish
- 12/27/22
- Bill.com Holdings put volume heavy and directionally bearish
|
Recommendations
| ShowHide Related Items >><< - 08:33 Today
- NetSol Technologies extends its partnership with Amazon Web Services
- 02/02/23
- Amazon says YTD AWS revenue growth in mid-teens y/y so far
- 02/02/23
- Amazon saw continued efficiencies in transportation network in Q4
- 02/02/23
- Amazon down 5% ahead of Q4 earnings call
- $188.78 /
+35.675 (+23.30%) - 02/01/23
- Meta cuts FY23 total expenses view to $89B-$95B from $94B-$100B
- 02/01/23
- Meta says 2023 will be 'a year of efficiency'
- 02/01/23
- Meta Platforms announces $40B increase in share repurchase authorization
- 02/01/23
- Meta Platforms reports FoA and RL segment restructuring charges
- $107.71 /
+7.275 (+7.24%) - 02/02/23
- Alphabet says started bringing revenue sharing to YouTube Shorts
- 02/02/23
- Alphabet reports Q4 Google Cloud revenue $7.3B vs. $5.54B last year
- 02/02/23
- Alphabet taking actions to optimize global office space
- 02/01/23
- 'Tomb Raider Reloaded' coming to Google Play, iOS, Netflix on February 14
- 08:31 Today Evercore ISI
- Amazon price target raised to $160 from $150 at Evercore ISI
- 08:13 Today Wedbush
- Amazon.com price target lowered to $125 from $140 at Wedbush
- 08:13 Today Susquehanna
- Amazon.com price target raised to $150 from $140 at Susquehanna
- 07:58 Today Morgan Stanley
- Amazon price target raised to $150 from $140 at Morgan Stanley
- $188.78 /
+35.675 (+23.30%) - 05:48 Today HSBC
- Meta Platforms downgraded to Reduce from Hold at HSBC
- 05:13 Today DZ Bank
- Meta Platforms upgraded to Hold from Sell at DZ Bank
- 02/02/23 Deutsche Bank
- Meta Platforms price target raised to $200 from $125 at Deutsche Bank
- 02/02/23 RBC Capital
- Meta Platforms price target raised to $225 from $160 at RBC Capital
- $107.71 /
+7.275 (+7.24%) - 08:13 Today Roth MKM
- Alphabet price target raised to $126 from $120 at Roth MKM
- 07:36 Today JPMorgan
- Alphabet price target raised to $118 from $115 at JPMorgan
- 07:28 Today Credit Suisse
- Alphabet price target lowered to $136 from $145 at Credit Suisse
- 07:18 Today Morgan Stanley
- Alphabet price target raised to $135 from $125 at Morgan Stanley
- 02/02/23
- Amazon sees Q1 revenue $121B-$126B, consensus $125.11B
- 02/02/23
- Amazon reports Q4 EPS 3c with Rivian loss, consensus 17c
- 02/02/23
- Notable companies reporting after market close
- 10/27/22
- Amazon sees Q4 revenue $140B-$148B, consensus $155.15B
- $188.78 /
+35.675 (+23.30%) - 02/01/23
- Meta Platforms sees Q1 revenue $26B-$28.5B, consensus $27.14B
- 02/01/23
- Meta Platforms reports Q4 EPS $1.76, consensus $2.22
- 02/01/23
- Notable companies reporting after market close
- 11/09/22
- Meta Platforms backs Q4 revenue outlook $30B-$32.5B, consensus $31.52B
- $107.71 /
+7.275 (+7.24%) - 02/02/23
- Alphabet reports Q4 EPS $1.05, consensus $1.18
- 02/02/23
- Notable companies reporting after market close
- 10/25/22
- Alphabet reports Q3 EPS $1.06, consensus $1.25
- 10/25/22
- Notable companies reporting after market close
- 02/02/23
- Beyond Meat revamps retail sales strategy around five grocers, WSJ says
- 02/01/23
- Judge rules Amazon supervisors broke law in anti-union efforts, NYTimes reports
- 02/01/23
- Amazon's layoffs hit robotics, grocery, health, AWS units, CNBC reports
- 01/29/23
- Amazon raises price minimum for free grocery delivery, WSJ reports
- $188.78 /
+35.675 (+23.30%) - 02/02/23
- FTC denies Meta request to bar Khan from antitrust case, Bloomberg says
- 02/01/23
- GoodRx to pay $1.5M fine over sharing health data, Bloomberg Law reports
- 02/01/23
- Meta wins approval over FTC to acquire Within Unlimited, Bloomberg says
- 02/01/23
- Meta debates on whether to share Reel money with creators, Information reports
- $107.71 /
+7.275 (+7.24%) - 02/02/23
- Democratic senator joins calls to ban TikTok, WSJ reports
- 02/01/23
- GoodRx to pay $1.5M fine over sharing health data, Bloomberg Law reports
- 02/01/23
- Google testing ChatGPT-like products, including 'Apprentice Bard,' CNBC reports
- 01/31/23
- Reels sharing revenue with creators hotly debated within Meta, Information says
- 02/02/23
- Fly Intel: After-Hours Movers
- 02/02/23
- What Wall Street is saying about Alphabet ahead of earnings
- 02/01/23
- Here's what Wall Street is saying about Amazon ahead of earnings
- 01/30/23
- Fly Intel: Pre-market Movers
- $188.78 /
+35.675 (+23.30%) - 02/02/23
- What You Missed On Wall Street On Thursday
- 02/02/23
- What You Missed On Wall Street This Morning
- 02/02/23
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 02/02/23
- Fly Intel: Pre-market Movers
- $107.71 /
+7.275 (+7.24%) - 02/02/23
- Fly Intel: After-Hours Movers
- 02/02/23
- What You Missed On Wall Street On Thursday
- 02/02/23
- What You Missed On Wall Street This Morning
- 02/02/23
- What Wall Street is saying about Alphabet ahead of earnings
- 02/02/23
- Amazon options imply 7.0% move in share price post-earnings
- 02/02/23
- Notable open interest changes for February 2nd
- 01/31/23
- Notable open interest changes for January 31st
- 01/30/23
- Notable open interest changes for January 30th
- $188.78 /
+35.675 (+23.30%) - 07:35 Today
- Unusual call flow in option market yesterday
- 02/02/23
- Earnings season driving record option volume
- 02/02/23
- Early notable gainers among liquid option names on February 2nd
- 02/02/23
- Notable open interest changes for February 2nd
- $107.71 /
+7.275 (+7.24%) - 02/02/23
- Alphabet Class A options imply 5.4% move in share price post-earnings
- 02/02/23
- Early notable gainers among liquid option names on February 2nd
- 01/20/23
- Early notable gainers among liquid option names on January 20th
- 01/20/23
- Unusually active option classes on open January 20th
|
Hot Stocks
| ShowHide Related Items >><< - 01/04/23
- Personalis up over 5% at $2.30 after raising FY22 revenue guidance
- 12/14/22
- Personalis CEO West to retire
- 11/30/22
- Personalis and UCSF to study utility of ctDNA for treatment response in CRC
- 10/04/22
- Personalis enters gastroesophageal cancer research pact with Duke, Olink
- $176.35 /
+2.105 (+1.21%) - 01/30/23
- Moderna granted Breakthrough Therapy Designation for mRNA-1345
- 01/17/23
- Moderna jumps 7% to $203.21 after announcing data from mRNA-13 efficacy trial
- 01/17/23
- Moderna announces data from efficacy trial of mRNA-1345 targeting RSV
- 01/13/23
- FDA sees preliminary safety signal for older users of Pfizer bivalent vaccine
- 11/03/22 Citi
- Personalis price target lowered to $6 from $8 at Citi
- 11/03/22 H.C. Wainwright
- Personalis price target lowered to $13 from $26 at H.C. Wainwright
- 08/04/22 H.C. Wainwright
- Personalis price target lowered to $26 from $30 at H.C. Wainwright
- 05/05/22 Citi
- Personalis price target lowered to $14 from $18 at Citi
- $176.35 /
+2.105 (+1.21%) - 01/25/23 Cowen
- Moderna price target raised to $150 from $130 at Cowen
- 01/18/23 Chardan
- Moderna price target raised to $208 from $191 at Chardan
- 01/18/23 SVB Securities
- Moderna price target raised to $111 from $102 at SVB Securities
- 01/11/23 Deutsche Bank
- Moderna price target raised to $225 from $185 at Deutsche Bank
- 01/04/23
- Personalis raises FY22 revenue view to about $65M, consensus $63.6M
- 01/04/23
- Personalis sees Q4 revenue approximately $16.7M, consensus $15.33M
- 11/02/22
- Personalis sees FY22 revenue $63M-$64M, consensus $64.4M
- 11/02/22
- Personalis reports Q3 EPS (58c), consensus (64c)
- $176.35 /
+2.105 (+1.21%) - 11/03/22
- Moderna reports Q3 EPS $2.53, consensus $3.29
- 11/02/22
- Notable companies reporting before tomorrow's open
- 11/02/22
- Notable companies reporting before tomorrow's open
- $176.35 /
+2.105 (+1.21%) - 02/01/23
- Novavax refuses to refund $700M for COVID shots never delivered, NY Times says
- 01/27/23
- FDA advisors recommend replacing original COVID-19 vaccine, CNBC reports
- 01/09/23
- Moderna considering $110-$130 for COVID shot, similar to Pfizer's, WSJ says
- 12/24/22
- Pfizer, Moderna among vaccine makers to watch in 2023, Barron's says
- 01/04/23
- Fly Intel: After-Hours Movers
- 12/14/22
- Fly Intel: After-Hours Movers
- $176.35 /
+2.105 (+1.21%) - 01/18/23
- What You Missed On Wall Street On Wednesday
- 01/18/23
- What You Missed On Wall Street This Morning
- 01/17/23
- Fly Intel: After-Hours Movers
- 01/10/23
- What You Missed On Wall Street On Tuesday
- $176.35 /
+2.105 (+1.21%) - 01/30/23
- Moderna put volume heavy and directionally bearish
- 01/18/23
- Early notable gainers among liquid option names on January 18th
- 01/18/23
- Unusually active option classes on open January 18th
- 12/30/22
- Unusually active option classes on open December 30th
|
Hot Stocks
| ShowHide Related Items >><< - 01/12/23
- Conduent launches IntelliHealth module for healthcare provider engagement
- 12/19/22
- Conduent selected to provide EMV contactless payment system for Venice
- 12/07/22
- Conduent implements electronic ticketing system on Italian bus network
- 12/01/22
- Conduent introduces VeriSight solutions to combat fraud
- 05/31/22 Gordon Haskett
- Conduent 'overdue to be sold,' says Gordon Haskett
- 02/17/22 Cowen
- Conduent price target lowered to $5 from $6 at Cowen
- 11/01/22
- Conduent sees 2022 revenue $3.85B-$3.95B, consensus $3.91B
- 11/01/22
- Conduent reports Q3 adjusted EPS 9c, consensus 8c
|
Hot Stocks
| ShowHide Related Items >><< - 12/22/22
- Park Hotels & Resorts reports November RevPAR up 48.9% y-o-y to $156.14
- 12/07/22
- Park Hotels & Resorts declares Q4 dividend of 25c per share
- 01/10/23 Barclays
- Park Hotels & Resorts price target lowered to $15 from $18 at Barclays
- 01/03/23 SMBC Nikko
- Park Hotels & Resorts downgraded to Underperform from Neutral at SMBC Nikko
- 12/05/22 Morgan Stanley
- Park Hotels & Resorts initiated with an Equal Weight at Morgan Stanley
- 10/25/22 Deutsche Bank
- Park Hotels & Resorts price target lowered to $21 from $26 at Deutsche Bank
- 12/22/22
- Park Hotels & Resorts raises Q4 adjusted FFO view to 38c-45c from 35c-43c
- 08/03/22
- Park Hotels & Resorts sees Q3 adjusted FFO 34c-43c
- 08/03/22
- Park Hotels & Resorts reports Q2 adjusted FFO 61c, consensus 49c
- 12/22/22
- What You Missed On Wall Street On Thursday
- 12/22/22
- What You Missed On Wall Street This Morning
- 12/22/22
- Fly Intel: Pre-market Movers
- 10/18/22
- What You Missed On Wall Street This Morning
|
Downgrade
| ShowHide Related Items >><< - 12/28/22
- Rush Street selects Konami's SYNKROS system for Rivers Casino Portsmouth
- 01/11/23 JPMorgan
- Konami Holdings downgraded to Neutral from Overweight at JPMorgan
- 09/30/22 Macquarie
- Konami Holdings downgraded to Neutral from Outperform at Macquarie
- 09/07/22 Goldman Sachs
- Konami Holdings resumed with a Buy at Goldman Sachs
- 03/08/22 Citi
- Konami Holdings upgraded to Buy from Neutral at Citi
|
Options
| ShowHide Related Items >><< - 02/02/23
- Mullen, Loop, Menzies pilot EV vans at Los Angeles International Airport
- 01/25/23
- Mullen Automotive says 'no plans at current time to effect reverse split'
- 12/22/22
- Mullen Automotive announces I-GO arrived in Europe
- 12/20/22
- Mullen Automotive closes Mullen FIVE Strikingly Different Tour
- 01/10/23
- Frontline rises 24.7%
- 01/10/23
- Frontline rises 17.1%
- 01/10/23
- Frontline rises 21.7%
- 01/09/23
- Frontline terminates combination agreement with Euronav
- 01/25/23
- Nikola introduces new hydrogen energy brand "HYLA"
- 01/25/23
- Nikola: Biagi Bros. to take delivery of 15 Nikola Tre FCEVs in Q4
- 01/24/23
- Nikola and Fortescue Future Industries execute MOU for green hydrogen facilities
- 01/18/23
- Nikola launches first hydrogen mobile fueler
- 02/02/23
- Dutch Bros CEO sells $6.0M in common stock
- 01/09/23
- Dutch Bros rises 9.3%
- 11/09/22
- Dutch Bros CEO: No good news on inflation
- 09/20/22
- Dutch Bros appoints Victoria Tullett as chief legal officer
- 12/02/22
- Community Health chairman Wayne Smith to retire
- 11/28/22
- Community Health falls -14.4%
- 11/28/22
- Community Health falls -6.5%
- 12/28/22
- Meta Materials to showcase global technology collaborations at CES 2023
- 12/15/22
- Meta Materials completes distribution of Next Bridge Hydrocarbon shares
- 12/07/22
- Meta Materials says FINRA processed corporate action for exchange of Series A
- 12/06/22
- Meta Materials announces results of Annual Meeting of Shareholders
- 01/24/23
- QuantumScape falls -17.6%
- 01/24/23
- Quantumscape trading resumes
- 01/24/23
- Quantumscape trading halted, volatility trading pause
- 01/17/23
- QuantumScape falls -8.7%
- 01/05/23
- Cathie Wood's ARK Investment bought 415.4K shares of SomaLogic today
- 01/04/23
- Cathie Wood's ARK Investment bought 313K shares of SomaLogic today
- 01/03/23
- Cathie Wood's ARK Investment bought 288K shares of SomaLogic today
- 12/19/22
- SomaLogic offers 7,000-plex SomaScan platform as Japan's first SomaLogic site
- 12/15/22
- AST SpaceMobile, NASA sign joint deal to improve spaceflight safety
- 12/13/22
- AST SpaceMobile says on track to deliver first space-based broadband
- 11/14/22
- Greenlight takes new stake in Intel, exits position in Atlas Air
- 11/14/22
- AST SpaceMobile deploys commercial communications array in low Earth orbit
- 01/18/23
- Novavax Nuvaxovid COVID-19 vaccine approved in South Korea as adult booster
- 01/09/23
- Novavax names John Jacobs as new CEO, succeeding Stanley Erck
- 12/30/22
- Novavax announces initiation of Phase2 trial for CIC, influenza vaccines
- 12/21/22
- Novavax to initiate phase 2 influenza CIC trial by end 2022
- 01/12/23 Deutsche Bank
- Frontline price target raised to $16.50 from $15 at Deutsche Bank
- 01/11/23 JonesResearch
- Euronav NV upgraded to Buy from Hold at JonesResearch
- 01/10/23 Stifel
- Euronav NV downgraded to Hold from Buy at Stifel
- 11/29/22 Jefferies
- Frontline price target raised to $17 from $16 at Jefferies
- 01/17/23 BTIG
- Nikola price target lowered to $5 from $7 at BTIG
- 01/12/23 Northland
- Supplier news timing 'couldn't be worse' for Lightning eMotors, says Northland
- 12/15/22 RBC Capital
- Plug Power, Nikola partnership 'not a total surprise,' says RBC Capital
- 11/04/22 Cowen
- Nikola price target lowered to $10 from $12.50 at Cowen
- 01/26/23 Barclays
- Dutch Bros price target raised to $31 from $29 at Barclays
- 01/24/23 Wedbush
- Dutch Bros initiated with a Neutral at Wedbush
- 01/05/23 Baird
- Baird remains very bullish on long-term fundamentals at Dutch Bros
- 01/05/23 Barclays
- Dutch Bros price target lowered to $29 from $30 at Barclays
- 08/04/22 Citi
- Community Health price target lowered to $6 from $14 at Citi
- 07/29/22 Oppenheimer
- Community Health price target lowered to $6 from $16 at Oppenheimer
- 06/16/22 Loop Capital
- Loop starts Community Health at Hold amid labor challenges
- 06/16/22 Loop Capital
- Community Health initiated with a Hold at Loop Capital
- 01/25/23 Morgan Stanley
- QuantumScape price target lowered to $3 from $4 at Morgan Stanley
- 12/13/22 Goldman Sachs
- QuantumScape downgraded to Sell from Neutral at Goldman Sachs
- 11/09/22 Morgan Stanley
- Morgan Stanley cuts QuantumScape to Underweight after 'narrative changing' Q3
- 11/09/22 Morgan Stanley
- QuantumScape downgraded to Underweight from Equal Weight at Morgan Stanley
- 08/16/22 Cowen
- SomaLogic price target lowered to $9 from $11 at Cowen
- 06/23/22 Cowen
- SomaLogic price target lowered to $11 from $14 at Cowen
- 05/13/22 Canaccord
- SomaLogic price target lowered to $15 from $19 at Canaccord
- 03/30/22 Canaccord
- SomaLogic initiatives should drive long-term growth, says Canaccord
- 11/23/22 Deutsche Bank
- AST SpaceMobile price target raised to $32 from $30 at Deutsche Bank
- 10/28/22 B. Riley
- AST SpaceMobile initiated with a Buy at B. Riley
- 10/19/22 Barclays
- AST SpaceMobile price target lowered to $15 from $29 at Barclays
- 08/17/22 Deutsche Bank
- AST SpaceMobile price target lowered to $30 from $31 at Deutsche Bank
- 01/09/23 B. Riley
- Novavax price target lowered to $37 from $74 at B. Riley
- 12/30/22 H.C. Wainwright
- Novavax price target lowered to $110 from $207 at H.C. Wainwright
- 11/10/22 B. Riley
- Novavax price target lowered to $74 from $83 at B. Riley
- 10/14/22 B. Riley
- Novavax price target lowered to $83 from $126 at B. Riley
- 11/30/22
- Frontline reports Q3 adjusted EPS 37c vs. 21c last quarter
- 08/25/22
- Frontline reports Q2 adjusted EPS 21c vs. (1c) last quarter
- 11/03/22
- Nikola reports Q3 adjusted EPS (28c), consensus (39c)
- 11/02/22
- Notable companies reporting before tomorrow's open
- 11/02/22
- Notable companies reporting before tomorrow's open
- 08/04/22
- Nikola sees Q3 revenue $21.13M-$24.38M, consensus $38.65M
- 11/09/22
- Dutch Bros sees 2022 revenue at least $725M, consensus $724.5M
- 11/09/22
- Dutch Bros reports Q3 EPS 9c, consensus 8c
- 08/10/22
- Dutch Bros backs FY22 revenue view at least $715M, consensus $713.11M
- 08/10/22
- Dutch Bros reports Q2 adjusted EPS 5c, consensus 7c
- 10/26/22
- Notable companies reporting after market close
- 10/26/22
- QuantumScape reports Q3 EPS (27c), consensus (21c)
- 01/09/23
- SomaLogic sees 2022 revenue at high-end of $93M-$98M, consensus $95M
- 11/14/22
- SomaLogic sees FY22 revenue $93M-$98M, consensus $83.02M
- 11/14/22
- SomaLogic reports Q3 EPS (18c), consensus (20c)
- 08/15/22
- SomaLogic reports Q2 EPS (13c), consensus (18c)
- 08/15/22
- AST SpaceMobile reports Q2 EPS (6c) vs. (39c) last year
- 12/14/22
- Novavax reaffirms FY22 revenue guidance approximately $2B, consensus $2.1B
- 11/08/22
- Novavax sees FY22 revenue $2B, consensus $2.04B
- 11/08/22
- Novavax reports Q3 EPS ($2.15) vs. ($4.31) last year
- 08/08/22
- Novavax cuts FY22 revenue view to $2B-$2.3B from $4B-$5B, consensus $4.27B
|
Recommendations
| ShowHide Related Items >><< - 12/01/22
- Marriott Vacations raises quarterly dividend by 16% to 72c per share
- 11/15/22 Truist
- Marriott Vacations price target raised to $205 from $202 at Truist
- 11/02/22 Credit Suisse
- Marriott Vacations price target lowered to $219 from $227 at Credit Suisse
- 08/12/22 Truist
- Marriott Vacations price target lowered to $202 from $205 at Truist
- 08/10/22 Barclays
- Marriott Vacations price target raised to $165 from $136 at Barclays
- 10/31/22
- Marriott Vacations raises FY22 adjusted EPS to $10.20-$10.64, consensus $9.94
- 10/31/22
- Marriott Vacations reports Q3 adjusted EPS $3.02, consensus $2.60
- 08/08/22
- Marriott Vacations sees FY22 adjusted EPS $9.47-$10.35, consensus $9.49
- 08/08/22
- Marriott Vacations reports Q2 adjusted EPS $2.87, consensus $2.27
|
Downgrade
| ShowHide Related Items >><< - 05:06 Today Jefferies
- Travel + Leisure downgraded to Hold from Buy at Jefferies
- 11/15/22 Truist
- Travel + Leisure price target lowered to $60 from $72 at Truist
- 10/28/22 Deutsche Bank
- Travel + Leisure price target lowered to $62 from $69 at Deutsche Bank
- 10/28/22 Credit Suisse
- Travel + Leisure downgraded to Underperform from Outperform at Credit Suisse
- 10/27/22
- Travel + Leisure sees FY22 adjusted EBITDA $855M-$865M
- 10/27/22
- Travel + Leisure reports Q3 adjusted EPS $1.28, consensus $1.30
- 09/15/22
- Travel + Leisure backs Q3 adjusted EBITDA view $230M-$240M
- 12/14/22
- Fly Intel: After-Hours Movers
- 10/28/22
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 09/16/22
- What You Missed On Wall Street On Friday
- 09/16/22
- What You Missed On Wall Street This Morning
|